stockportfolio.pro
Vertex Pharmaceuticals Incorporated Shares Outstanding 2008–2025
Vertex Pharmaceuticals Incorporated (VRTX) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 254.0M | -1.1% |
| FY 2024 | 256.9M | -0.3% |
| FY 2023 | 257.7M | +0.3% |
| FY 2022 | 257.0M | +1.0% |
| FY 2021 | 254.5M | -2.1% |
| FY 2020 | 259.9M | +0.3% |
| FY 2019 | 259.0M | +1.5% |
| FY 2018 | 255.2M | +0.8% |
| FY 2017 | 253.3M | +2.0% |
| FY 2016 | 248.3M | +0.8% |
| FY 2015 | 246.3M | +1.9% |
| FY 2014 | 241.8M | +3.4% |
| FY 2013 | 233.8M | +7.6% |
| FY 2012 | 217.3M | +3.8% |
| FY 2011 | 209.3M | +2.8% |
| FY 2010 | 203.5M | +1.8% |
| FY 2009 | 200.0M | — |
| FY 2008 | 0.0M | — |
Source: Vertex Pharmaceuticals Incorporated SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Vertex Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVertex Pharmaceuticals Incorporated — frequently asked questions
What is Vertex Pharmaceuticals Incorporated's shares outstanding?
Vertex Pharmaceuticals Incorporated (VRTX) reported shares outstanding of 254.0M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Vertex Pharmaceuticals Incorporated's official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.